News & Analysis on Clinical Trial Services & Contract Research And Development
The global market for in vitro toxicity testing is predicted to reach $8.8bn by 2023 – and demand is expected to increase, driven by new technologies and regulations, says Charles River.
Accelovance and Linical merged in March of this year to create a global midsized CRO for which ‘future possibilities are endless,’ says newly appointed CEO.
GNS Healthcare will use its machine learning platform to create an ALS disease model to further research and understanding of the disease.
Unreported electronic data and a lack of review criteria and methodology were cited in the US FDA warning letter.
Health Canada has announced that due to manufacturing issues, pharmacies could run out of supplies of EpiPens during the month of August.
An accident at Sanofi’s facility in Ireland has left two of its employees hospitalised.